Brainstorm Cell Therapeutics (BCLI) Enters 2.5M Common Warrant Exercise Agreement

January 8, 2015 9:46 AM EST Send to a Friend
Brainstorm Cell Therapeutics (NASDAQ: BCLI) announced it has entered into a Warrant Exercise Agreement with certain holders of warrants issued ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login